Krish S. Krishnan, President and CEO at Krystal Biotech, Inc. (KRYS), sold 98,900 shares at $177.66 ($17.6M) on 2025-03-13, disclosed to the SEC on 2025-03-13.
Scheduled sale ($17.6M) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $175.83 | 1,100 | $193K | 1.1% |
| 2 | $175.97 | 1,639 | $288K | 1.6% |
| 3 | $175.97 | 1,639 | $288K | 1.6% |
| 4 | $176.80 | 4,944 | $874K | 5.0% |
| 5 | $176.80 | 4,944 | $874K | 5.0% |
| 6 | $176.88 | 4,579 |
| $810K |
| 4.6% |
| 7 | $176.88 | 4,579 | $810K | 4.6% |
| 8 | $177.62 | 10,931 | $1.9M | 11.0% |
| 9 | $177.62 | 10,931 | $1.9M | 11.0% |
| 10 | $177.66 | 10,937 | $1.9M | 11.0% |
| 11 | $177.66 | 10,937 | $1.9M | 11.0% |
| 12 | $178.76 | 6,514 | $1.2M | 6.6% |
| 13 | $178.76 | 6,514 | $1.2M | 6.6% |
| 14 | $178.77 | 6,769 | $1.2M | 6.9% |
| 15 | $178.77 | 6,769 | $1.2M | 6.9% |
| 16 | $179.55 | 1,331 | $239K | 1.4% |
| 17 | $179.55 | 1,331 | $239K | 1.4% |
| 18 | $179.57 | 1,256 | $226K | 1.3% |
| 19 | $179.57 | 1,256 | $226K | 1.3% |
| Total | $177.81 avg | 98,900 | $17.6M | 100% |
| Filing → |
| KRYS | SELL | 2026-03-06 | $13.2M | — | Filing → |
| KRYS | SELL | 2025-12-05 | $20.9M | — | Filing → |
| KRYS | SELL | 2025-07-16 | $10.1M | — | Filing → |